Physician

Asghar A Rizvi, MD

According to 2025 Medicare claims, Asghar Rizvi, MD (NPI: 1023245925) practices interventional pain management (ipm) in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is STELLAR PAIN AND SPINE SPECIALISTS (NPI: 1154777159; TIN: 812426307) and primary practice location at 60622-5684.

Rizvi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 349 traditional Medicare patients, billed 1,677 HCPCS/CPT codes, and received $154,618 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 532 prescription claims across 158 beneficiaries totaling $8,273 in drug costs, led by Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen). 2021 DME data shows 12 claims. Open Payments data shows 4 records totaling $198. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $241,056 and ending at $154,618. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $136,727 to $8,273. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $31,130 to $1,038.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	373	3,751	$241,056
2016	399	3,038	$131,695
2017	351	8,013	$192,794
2018	377	8,412	$202,585
2019	320	8,449	$175,379
2020	186	1,741	$47,602
2021	240	1,407	$110,395
2022	262	1,415	$110,531
2023	300	1,491	$118,662
2024	349	1,677	$154,618

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	365	2,802	$136,727
2016	294	1,569	$79,625
2017	163	656	$23,275
2018	132	676	$22,118
2019	135	750	$28,016
2020	84	239	$5,392
2021	60	130	$1,323
2022	90	269	$2,473
2023	150	483	$7,517
2024	158	532	$8,273

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	40	233	$26,547
2016	58	141	$10,705
2017	N/R	46	$2,431
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	12	$1,038
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	99	99	$105
64483	Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level	61	69	$104
01940	Anesthesia for nerve destruction procedures on spine or spinal cord of lower back accessed through skin using imaging guidance	39	39	$100
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	235	677	$81
64484	Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level	39	42	$42

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	130	3,135	$2,629
Morphine Sulfate Er	Morphine Sulfate	40	1,132	$1,013
Pregabalin	Pregabalin	56	1,635	$900
Gabapentin	Gabapentin	87	2,545	$718
Oxycodone Hcl	Oxycodone Hcl	12	301	$177

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$198	Stryker Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Asghar A. Rizvi, MD?

Tedicare shows public-source Medicare data for Asghar A. Rizvi, MD (NPI 1023245925), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Asghar A. Rizvi, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Asghar A. Rizvi, MD?

Asghar A. Rizvi, MD is linked to STELLAR PAIN AND SPINE SPECIALISTS (billing NPI 1154777159) in the available physician profile data.

Does Asghar A. Rizvi, MD have Open Payments data?

Asghar A. Rizvi, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.